A recent study indicates that individuals who stop using popular weight-loss injections like Mounjaro or Wegovy may regain reduced body mass much more quickly than those who halt conventional lifestyle regimens.
Published data in a major health publication demonstrates that while obese people can lose substantial amounts of their body weight while undergoing treatment, the mass comes back at an estimated rate of nearly a kilo each month once they quit.
"Individuals buying these medications should be informed of the danger of fast weight regain when the medication ends," warns researcher Dr. Susan Jebb.
This pace of recovery implies a reversion to starting mass in about a year and a half.
Comparing Therapies
The study, which examined dozens of studies involving over 9,000 of patients, contrasted the results of these new drugs with conventional dieting.
Scientists emphasize that individuals who lose weight through diet and exercise generally have a slower weight regain—perhaps 0.1 kg a month—post-intervention.
Explaining the Quick Regain
Experts suggest the mechanism of the drugs is key to understanding the amplified regain.
The injections mimic a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Sustained high doses of GLP-1 levels several times higher than the body's typical production might result in the system to produce less of its own natural hormone, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition expert.
"Withdrawal of this medication results in appetite is no longer kept in check, making excessive eating much more probable."
A Lifelong Disease?
Health authorities advise the injections for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Many experts say that, considering the high risk of weight regain, the treatment is often life-long.
This view is supported by pharmaceutical companies, who say that the results "underscore the persistent character of obesity," comparing it to managing diseases like hypertension.
User Testimonies
Users who have come off the medication explain a sudden resurgence of appetite.
"It was like something that goes on and I was suddenly starving," said an individual.
This challenge is compounded if users have not developed sustainable lifestyle or habit modifications during treatment.
Growing Interest
Survey data indicate that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.
- Use is more common among women than males.
- The 40s and 50s age group shows the highest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than the NHS.
In conclusion, researchers emphasize that while GLP-1 drugs are potent agents for shedding pounds, they are not a permanent fix and long-term success relies on ongoing behavioural management.